Vaxfab Enterprises Limited has issued an intimation of a scheduled Board of Directors meeting. The meeting is set to be held on Saturday, November 14, 2026.
The primary purpose of the meeting is to consider and approve the unaudited financial results of the Company for the quarter and half year ended on September 30, 2026.
The disclosure also confirms the ongoing closure of the trading window for dealing in the company's securities by all Designated Persons. The trading window was closed effective October 1, 2026, as previously intimated on September 28, 2026. The closure will continue to remain in effect until 48 hours after the submission of the financial results for the quarter ended September 30, 2026.
The notice is signed by Ravindra Ashokbhai Joshi, Managing Director (DIN: 10112296), and is addressed to BSE Limited.